---
schema_version: "secwatch.filing_event.v1"
accession: "0000105418-26-000037"
form_type: "8-K"
ticker: "WMK"
cik: "0000105418"
company_name: "WEIS MARKETS INC"
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:27:10.212736+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Weis Markets Q1 revenue up 4.6% to $1.26B; net income jumps 42.5% to $27.85M

## Summary
- Total revenue $1.26B vs $1.20B (+4.6%); comp store sales ex-fuel +1.2% YoY, +2.2% two-year stacked.
- Net income $27.85M vs $19.55M (+42.5%); diluted EPS $1.13 vs $0.73.
- Pharmacy revenue hurt by ~$7.48M from Inflation Reduction Act MFP provisions effective Jan 1, 2026.
- Quarterly dividend $0.34/share, payable May 26, 2026 to shareholders of record May 11, 2026.
- CEO highlights record 2025 capex: 5 new stores, 7 remodels, 5 fuel centers, 1,000+ smaller projects.

## SEC filing metadata
- accession: 0000105418-26-000037
- form_type: 8-K
- ticker: WMK
- cik: 0000105418
- company_name: WEIS MARKETS INC
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/wmk-20260506x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000105418-26-000037
- JSON: https://secwatch.observer/filing/0000105418-26-000037.json
- Plain text: https://secwatch.observer/filing/0000105418-26-000037.txt

## Source-grounded claims
- claim_id: 340ba4b9fd758b4bca70e5b14826e712e59e6eb5
  claim: WEIS MARKETS INC reported first quarter ended March 28, 2026 results: revenue $1.26 billion, net income $27.85 million, EPS $1.13.
  evidence_excerpt: in the first quarter. We are grateful to our associates, whose hard work makes these solid results possible,” said Mr. Weis. ​ First Quarter 2026 Results ​ Total revenue was $1.26 billion for the 13-week first quarter ended March 28, 2026, compared to $1.20 billion for the same period in 2025, a 4.6% increase. Pharmacy revenue growth was unfavorably impacted by
  evidence_url: https://www.sec.gov/Archives/edgar/data/105418/000010541826000037/0000105418-26-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.